Diagnosis and Assessment of Pulmonary Arterial Hypertension

被引:834
作者
Badesch, David B. [1 ,2 ]
Champion, Hunter C. [3 ]
Gomez Sanchez, Miguel Angel [4 ]
Hoeper, Marius M. [5 ]
Loyd, James E. [6 ]
Manes, Alessandra [7 ]
McGoon, Michael [8 ]
Naeije, Robert [9 ,10 ]
Olschewski, Horst [11 ]
Oudiz, Ronald J. [12 ]
Torbicki, Adam [13 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Pulm Sci & Crit Care Med, Denver, CO USA
[2] Univ Colorado, Hlth Sci Ctr, Div Cardiol, Denver, CO 80262 USA
[3] Johns Hopkins Univ, Div Cardiol, Baltimore, MD USA
[4] Hosp Univ Doce de Octubre, Heart Failure & Pulm Hypertens Unit, Madrid, Spain
[5] Leibniz Univ Hannover, Sch Med, Dept Resp Med, Hannover, Germany
[6] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA
[7] Univ Bologna, Inst Cardiol, Bologna, Italy
[8] Mayo Clin, Coll Med, Rochester, MN USA
[9] Free Univ Brussels, Dept Pathophysiol, Erasme Acad Hosp, Brussels, Belgium
[10] Free Univ Brussels, Dept Cardiol, Erasme Acad Hosp, Brussels, Belgium
[11] Med Univ Graz, Univ Clin Internal Med, Pulmonol Div, Graz, Austria
[12] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Liu Ctr Pulm Hypertens, Torrance, CA 90509 USA
[13] Med Univ Warsaw, Dept Chest Med, Inst TB & Lung Dis, Warsaw, Poland
关键词
pulmonary arterial hypertension; diagnosis; assessment; CONTINUOUS INTRAVENOUS EPOPROSTENOL; ENDOTHELIN-RECEPTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; STRESS DOPPLER-ECHOCARDIOGRAPHY; MAXIMAL UPRIGHT EXERCISE; CALCIUM-CHANNEL BLOCKERS; OPERATION EVEREST-II; CARDIAC-OUTPUT; HIGH-ALTITUDE; SYSTEMIC-SCLEROSIS;
D O I
10.1016/j.jacc.2009.04.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The diagnosis and assessment of pulmonary arterial hypertension is a rapidly evolving area, with changes occurring in the definition of the disease, screening and diagnostic techniques, and staging and follow-up assessment. The definition of pulmonary hypertension has been simplified, and is now based on currently available evidence. There has been substantial progress in advancing the imaging techniques and biomarkers used to screen patients for the disease and to follow up their response to therapy. The importance of accurate assessment of right ventricular function in following up the clinical course and response to therapy is more fully appreciated. As new therapies are developed for pulmonary arterial hypertension, screening, prompt diagnosis, and accurate assessment of disease severity become increasingly important. A clear definition of pulmonary hypertension and the development of a rational approach to diagnostic assessment and follow-up using both conventional and new tools will be essential to deriving maximal benefit from our expanding therapeutic armamentarium. (J Am Coll Cardiol 2009;54:S55-66) (C) 2009 by the American College of Cardiology Foundation
引用
收藏
页码:S55 / S66
页数:12
相关论文
共 182 条
  • [1] REDUCTION OF STROKE VOLUME DURING EXERCISE IN MAN FOLLOWING ASCENT TO 3100 M ALTITUDE
    ALEXANDER, JK
    HARTLEY, LH
    MODELSKI, M
    GROVER, RF
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1967, 23 (06) : 849 - +
  • [2] N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension
    Andreassen, Arne K.
    Wergeland, Ragnhild
    Simonsen, Svein
    Geiran, Odd
    Guevara, Cecilia
    Ueland, Thor
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (04) : 525 - 529
  • [3] Primary pulmonary hypertension in Israel - A national survey
    Appelbaum, L
    Yigla, M
    Bendayan, D
    Reichart, N
    Fink, G
    Priel, I
    Schwartz, Y
    Richman, P
    Picard, E
    Goldman, S
    Kramer, MR
    [J]. CHEST, 2001, 119 (06) : 1801 - 1806
  • [4] Medical therapy for pulmonary arterial hypertension - Updated ACCP evidence-based clinical practice guidelines
    Badesch, David B.
    Abman, Steven H.
    Simonneau, Gerald
    Rubin, Lewis J.
    McLaughlin, Vallerie V.
    [J]. CHEST, 2007, 131 (06) : 1917 - 1928
  • [5] Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial
    Badesch, DB
    Tapson, VF
    McGoon, MD
    Brundage, BH
    Rubin, LJ
    Wigley, FM
    Rich, S
    Barst, RJ
    Barrett, PS
    Kral, KM
    Jöbsis, MM
    Loyd, JE
    Murali, S
    Frost, A
    Girgis, R
    Bourge, RC
    Ralph, DD
    Elliott, CG
    Hill, NS
    Langleben, D
    Schilz, RJ
    McLaughlin, VV
    Robbins, IM
    Groves, BM
    Shapiro, S
    Medsger, TA
    Gaine, SP
    Horn, E
    Decker, JC
    Knobil, K
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) : 425 - +
  • [6] Medical therapy for pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines
    Badesch, DB
    Abman, SH
    Ahearn, GS
    Barst, RJ
    McCrory, DC
    Simonneau, G
    McLaughlin, VV
    [J]. CHEST, 2004, 126 (01) : 35S - 62S
  • [7] BADUI E, 1985, Archivos del Instituto de Cardiologia de Mexico, V55, P263
  • [8] PULMONARY PRESSURE CARDIAC OUTPUT AND ARTERIAL OXYGEN SATURATION DURING EXERCISE AT HIGH ALTITUDE AND AT SEA LEVEL
    BANCHERO, N
    SIME, F
    PENALOZA, D
    CRUZ, J
    GAMBOA, R
    MARTICORENA, E
    [J]. CIRCULATION, 1966, 33 (02) : 249 - +
  • [9] ABNORMAL PULMONARY-ARTERY PRESSURE PROFILE AFTER CARDIAC TRANSPLANTATION - AN EXERCISE DOPPLER-ECHOCARDIOGRAPHIC STUDY
    BARBANT, SD
    REDBERG, RF
    TUCKER, KJ
    CHATTERJEE, K
    DEMARCO, T
    FOSTER, E
    SCHILLER, NB
    [J]. AMERICAN HEART JOURNAL, 1995, 129 (06) : 1185 - 1192
  • [10] Pulmonary hypertension in schistosomiasis mansoni
    Barbosa, MM
    Lamounier, JA
    Oliveira, EC
    Souza, MV
    Marques, DS
    Silva, AA
    Lambertucci, JR
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1996, 90 (06) : 663 - 665